EXECUTIVE ENGAGEMENTS
POOL
3953
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
712
Interactions with Platform & by Email
PARTICIPANTS
119
Unique # Participated
VALIDATIONS
34
Responses Validated*
COMPANIES
41
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
165
PAGES
236
EDITION
8
PRICE
USD 4950
CODE
MCP16214
*Engagement stats are ongoing and dynamic
Login to access data silos
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Biopharmaceutical Fermentation Systems estimated at US$10.9 Billion in the year 2020, is projected to reach a revised size of US$14.8 Billion by 2027, growing at aCAGR of 4.5% over the period 2020-2027. Upstream Products, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$5.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Downstream Products segment is readjusted to a revised 5% CAGR for the next 7-year period.
The Biopharmaceutical Fermentation Systems market in the U.S. is estimated at US$3.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
SELECT PLAYERS
Becton, Dickinson and Company; Eppendorf AG; F. Hoffmann-La Roche AG; GE Healthcare; Lonza Group AG; Merck KgaA; Nova Biomedical Corporation; Sartorius Stedim Biotech SA; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications) » End-Use (Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry, Other End-Uses) » Product (Upstream Products, Downstream Products)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Biopharmaceutical Fermentation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biopharmaceutical Fermentation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Upstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Upstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Upstream Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Downstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Downstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Downstream Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Recombinant Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Contract Manufacturing Organizations (CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Manufacturing Organizations (CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Manufacturing Organizations (CMOs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic and Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Food Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Food Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Food Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 41 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com